Backabrdn Life Sciences Investors Overview

abrdn Life Sciences Investors Receivables

Latest receivables for HQL: $1.3M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$1.28M
↓ 80.01% YoYΔ $-5.11M vs prior year quarter

Peer trimmed avg / median

Loading

abrdn Life Sciences Investors Receivables History

Loading

abrdn Life Sciences Investors vs. peers: Receivables Comparison

Loading

abrdn Life Sciences Investors Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

abrdn Life Sciences Investors (HQL) FAQ

As of the most recent data (March 2026), HQL shows a receivables of $1.3M. That compares with $6.4M in the prior-year period — down 80.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, HQL's receivables is now $1.3M (was $6.4M) — a 80.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether abrdn Life Sciences Investors is outperforming or lagging.

Tracking HQL's receivables over time shows whether abrdn Life Sciences Investors is scaling, shrinking, or reshaping that part of the business. The current reading is $1.3M That compares with $6.4M in the prior-year period — down 80.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has abrdn Life Sciences Investors's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $1.3M) with ownership activity and broader fundamentals.